Skip to main content
Premium Trial:

Request an Annual Quote

Europe Funds Alzheimer's, Brain Aging Systems Bio Consortium

NEW YORK (GenomeWeb News) – An international group of collaborators from academia and the business sector will partner to use integrative systems biology and comparative genomics approaches to study age-related human brain diseases with a particular focus on discovering new molecular targets and biomarkers for late-onset Alzheimer's disease.

The AgedBrainSYSBIO project, which is funded with €6 million ($7.7 million) from the European Commission, includes 14 partners in Belgium, France, Estonia, Germany, Israel, the UK, and Switzerland.

The idea behind the project is to take advantage of large data sets that have been generated through genome-wide association studies of genes linked with late-onset Alzheimer's risk and data from research on protein-protein interactions, and to apply these data and new drosophila and mouse models for Alzheimer's disease research.

The partners plan to integrate data sets from transciptomics, proteomics, metabolomics, and GWAS, and they will share results and knowledge from other studies and tests in humans and mouse models of age-related brain decline.

The private sector partners who will contribute to the project include Quretec, of Estonia, which will handle data management and analyses; Hybrigenics, of France, which conducts comparative proteomics and protein-protein interaction analyses; Germany's Genebridges, which develops strategies for DNA engineering in mammalian cells; and ReMynd, of Belgium, which supports the development of treatments for protein folding diseases through contract research activities for Alzheimer's disease, and drug discovery and development for Alzheimer's, Parkinson's, and diabetes.

The collaborators will work together to identify brain pathway interactions that develop through the natural aging process and compare them to those in the disease state. They also plan to model and test novel pathways and their evolutionary properties to identify potential drug targets for preventing and curing the cognitive effects of aging.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.